Yuto Kubo MD, PhD, Tomoki Makino MD, PhD, Makoto Yamasaki MD, PhD, Koji Tanaka MD, PhD, Kotaro Yamashita MD, PhD, Osamu Shiraishi MD, PhD, Keijiro Sugimura MD, PhD, Hiroshi Miyata MD, PhD, Masaaki Motoori MD, PhD, Kazumasa Fujitani MD, PhD, Atsushi Takeno MD, PhD, Motohiro Hirao MD, PhD, Yutaka Kimura MD, PhD, Taroh Satoh MD, PhD, Masahiko Yano MD, PhD, Hidetoshi Eguchi MD, PhD, Takushi Yasuda MD, PhD & Yuichiro Doki MD, PhD
Read Abstract:
Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer | SpringerLink